47
Participants
Start Date
December 31, 2004
Primary Completion Date
October 31, 2010
Study Completion Date
December 31, 2011
sorafenib tosylate
Given PO
pharmacological study
Correlative studies
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Wake Forest University Health Sciences, Winston-Salem
Emory University/Winship Cancer Institute, Atlanta
H. Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Cleveland Clinic Foundation, Cleveland
Henry Ford Hospital, Detroit
Adult Brain Tumor Consortium, Baltimore
Massachusetts General Hospital Cancer Center, Boston
National Cancer Institute (NCI)
NIH